ASX Share rice
Sun 09 Aug 2020 - 01:31:am (Sydney)

M7T Share Price

MACH7 TECHNOLOGIES LIMITEDM7THealth Care Equipment & Services

M7T Company Information

Name:

Mach7 Technologies Limited

Sector:

Healthcare

Industry:

Health Information Services

GIC Industry:

Health Care Technology

GIC Sub Industry:

Health Care Technology

Address:

120 Kimball Avenue South Burlington VT United States 05403

Phone:

802-861-7745

Founder & Chief Strategy Officer:

Mr. Ravi Krishnan

Global CFO & Corp. Sec.:

Ms. Jennifer Pilcher

MD & Director:

Mr. Michael Lampron

VP of Sales and Marketing:

Mr. Travis Nuzzi

Company Overview:

Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability solutions for healthcare enterprises worldwide. It offers Management Studio that enables healthcare delivery organizations to own, archive, and communicate imaging data from across the enterprise and connect that data with the electronic medical record. The company's Management Studio comprises enterprise imaging platform, vendor neutral archive, communication workflow engine, routing engine, fetching engine, and migration engine products. It also provides Diagnostic Studio that drives specialty workflows. The company's Diagnostic Studio solutions include PACS solution, Universal Worklist, and QC module. In addition, the company offers Clinical Studio, which provides access to view, navigate, review, and share patient medical data over the Web and across the enterprise. Its Clinical Studio solutions consist of clinical portal, clinical viewer, image sharing, and procedure import/export products. Further, the company provides professional services, such as implementation and training, data migration, support, and maintenance services; and archive migration services. Mach7 Technologies Limited was founded in 2007 and is based in South Burlington, Vermont.

M7T Share Price Information

Shares Issued:

182.83M

Market Capitalisation:

$170.03M

Revenue (TTM):

$14.91M

Revenue Per Share (TTM):

$0.10

Earnings per Share:

$-0.051

Profit Margin:

-0.1305

Operating Margin (TTM):

$-0.17

Return On Assets (TTM):

$-0.06

Return On Equity (TTM):

$-0.09

Quarterly Revenue Growth (YOY):

1.581

Gross Profit(TTM):

$-853,179

Diluted Earnings Per Share (TTM):

$-0.013

M7T CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-820,046

Change To Liabilities:

$611.82K

Total Cashflow From Investing Activities:

$-820,046

Net Borrowings:

$572.99K

Net Income:

$-7,058,729

Total Cash From Operating Activities:

$-2,904,042

Depreciation:

$1.94M

Other Cashflow From Investing Activities:

$-731,466

Change To Account Receivables:

$-439,226

Sale Purchase Of Stock:

$-203,856

Capital Expenditures:

$88.58K

M7T Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-7,822,709

Net Income:

$-7,058,729

Gross Profit:

$9.35M

Operating Income:

$-7,503,916

Other Operating Expenses:

$569.58K

Interest Expense:

$45.25K

Income Tax Expense:

$-763,980

Total Revenue:

$9.35M

Total Operating Expenses:

$16.85M

Cost Of Revenue:

$10.21M

M7T Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$10.59M

Total Liabilities:

$7.41M

Total Stockholder Equity:

$10.37M

Other Current Liabilities:

$3.48M

Total Assets:

$17.77M

Common Stock:

$58.85M

Other Current Assets:

$1.62M

Retained Earnings:

$-51,823,902

Other Liabilities:

$2.20M

Other Assets:

$748.38K

Cash:

$2.27M

Total Current Liabilities:

$5.20M

Short-Term Debt:

$613.49K

Property - Plant & Equipment:

$187.43K

Net Tangible Assets:

$-219,804

Long-Term Investments:

$318.02K

Total Current Assets:

$5.93M

Net Receivables:

$2M

Short-Term Investments:

$11.84M

Accounts Payable:

$342.81K

Non Currrent Assets (Other):

$748.38K

Short-Term Investments:

$11.84

Non Current Liabilities Total:

$2.20M

M7T Share Price History

M7T News

05 Aug, 2020
BURLINGTON, Vt., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Mach7 Technologies, a leading provider of data management and enterprise imaging solutions for healthcare organizations, announced today that Michigan Medicine has selected Mach7’s eUnity SMARTviewer for enterprise viewing.   Michigan Medicine, which includes the University of Michigan Health System, is the wholly owned academic medical center of the University of Michigan, in Ann Arbor. Delivering advanced clinical care, path-breaking research on human health and disease, and a broad range of biomedical education, Michigan Medicine has been nationally recognized for strong across-the-board performance for 27 consecutive years. They are ranked among the nation’s Honor Roll hospitals and number one in Michigan.eUnity is a powerful zero-footprint viewing and integration platform. It was selected by Michigan Medicine to support enterprise viewing across University of Michigan Medical Center, as well as all primary care, specialty care and affiliate centers. Clinicians will launch eUnity through the Epic patient portal to view up to 1 million studies annually.Mike Lampron, CEO of Mach7 Technologies said, “Michigan Medicine is one of the foremost health systems in America and we are honored to be given their trust as an imaging partner at the enterprise level. We look forward to growing with them as they expand to support patients and communities across the state.”About Mach7 TechnologiesMach7 Technologies (ASX:M7T) develops innovative data management solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s award-winning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit Mach7t.com.*Client Outlook is a subsidiary of Mach7About Michigan Medicine: At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our three hospitals, 125 clinics and home care operations that handle more than 2.3 million outpatient visits a year, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.Michigan Medicine includes the top ranked U-M Medical School and the University of Michigan Health System, which includes the C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, University Hospital, the Frankel Cardiovascular Center and the Rogel Cancer Center. Michigan Medicine’s adult hospitals were ranked no. 11 in the nation by U.S. News and World Report in 2019-20 and C.S. Mott Children’s Hospital was the only children’s hospital in Michigan nationally ranked in all 10 pediatric specialties analyzed by U.S. News and World Report for 2020-21. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $500 million. More information is available at www.michiganmedicine.org.For more information:Bob Tranchida VP of Marketing, Mach7 Technologies bob.tranchida@mach7t.com 802.861.7745
19 May, 2020
Mach7 Technologies Limited (ASX:M7T) shareholders will have a reason to smile today, with the analysts making...
07 Apr, 2020
Mach7 Technologies Limited (ASX:M7T), which is in the healthcare services business, and is based in United States, led...
23 Jan, 2020
Mach7 Technologies Limited's (ASX:M7T): Mach7 Technologies Limited provides enterprise imaging data sharing, storage...
05 Sep, 2019
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...